C5H9N3OS
159.21 g/mol
Pharmaceutical IntermediateWarning
Nizatidine impurity K
CAS148639-72-9
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
Nizatidine impurity K is a pharmaceutical intermediate used in the production of the histamine H2 receptor antagonist nizatidine. It is a structurally defined compound with the chemical designation This compound, serving as a reference or process-related impurity in manufacturing quality control.
Pharmaceutical intermediate for nizatidine manufacturingReference standard for impurity analysis in nizatidine production
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 148639-72-9
Related Compounds
ReferenceSame Category
(2S,5S)-1-(tert-Butoxycarbonyl)-5-hydroxypiperidine-2-carboxylic acid
CAS1487347-86-3
pharmaceutical intermediate
ReferenceSame Category
Bis(3-(perfluoroethyl)-1-(9-bromononyl)propyl) thioether
CAS148757-89-5
pharmaceutical intermediate
ReferenceSame Category
Methyl N-Boc-piperidine-3-carboxylate
CAS148763-41-1
pharmaceutical intermediate
ReferenceSame Category
Tert-butyl ((3R,5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate
CAS1488327-11-2
pharmaceutical intermediate
Referencestereoisomer of
N-Methyl-6-nitroso-3,4-dihydro-2H-1,4-thiazin-5-amine--hydrogen chloride (1/1)
CAS112233-23-5
research compound
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
N-(3-methyliminothiomorpholin-2-ylidene)hydroxylamine
InChIKey
IFDRXBBBALHODS-UHFFFAOYSA-N
SMILES
CN=C1C(=NO)SCCN1
Synonyms (10)
- NIZATIDINE IMPURITY K (EP IMPURITY)
- Rantidine EP impurity G
- Nizatidine impurity K